USANA (USNA) Q3 earnings report preview: what to look for

What happened

USANA Health Sciences, a health and wellness products company, is scheduled to report third-quarter earnings Tuesday after the market closes. Analysts expect revenue to grow 1.8% year over year, slower than the 6.7% increase in the same quarter last year.

Confirmed

Global impact / market context

Revenue growth is the money USANA brings in before costs, so the report can show whether demand is improving or weakening. A result below expectations could add pressure after last quarter’s revenue miss; stronger sales could help support expectations for the business.

Analyst inference

Analysts have generally kept their estimates unchanged over the past 30 days, indicating expectations for little change. USANA has missed revenue forecasts multiple times in two years, while peer results varied: Medifast sales fell and Vita Coco sales rose, so they offer mixed comparisons.

Confirmed

What to watch

1. Compare reported revenue with the expected 1.8% year-over-year growth; a shortfall would extend a pattern of forecast misses, while a stronger result would indicate firmer sales. Analyst inference
2. Check whether USANA explains changes in demand or its outlook; management’s comments could help investors judge whether slower expected growth is temporary or continuing. Analyst inference
3. Review earnings per share and EBITDA against analyst estimates. Last quarter EBITDA beat expectations, but earnings per share missed them, showing that profit measures can diverge. Confirmed

Evidence

• stockstory.org